Tetraffepir Injection

Adult dosage

Children aged 12 years and older and adults - Normal nutritional state or patients with mild metabolic stress: 0.6-0.9 g/kg of amino acids (0.10-0.15 g/kg of nitrogen) per day - Patients with moderate to severe metabolic stress: 0.9-1.6 g/kg of amino acids (0.15-0.25 g/kg of nitrogen) per day Dosage: 20-40 mL/kg per day (0.6-1.3 g/kg of amino acids, 0.10-

Children's dosage

Children aged 2-11 years Dosage: Regularly adjusted according to needs, up to a maximum of 40 mL/kg per day Administration rate: Do not exceed 3.0 mL/kg per hour Recommended administration duration: 12-24 hours Minimum administration duration (recommended

This medication must be used strictly according to a doctor's instructions, and should not be stopped or changed based on self-judgment. If allergic reactions such as fever, chills, skin rash, or difficulty breathing occur, discontinue administration immediately and inform medical personnel. Caution is necessary as dangerous precipitates can occur when used with other intravenous calcium-containing products or certain antibiotics; do not administer them simultaneously. Particularly, this medication may be risky for premature infants or low-birth-weight infants, and should be avoided in cases of severe respiratory illness. Patients with allergies to fish, eggs, soybeans, peanuts, or patients with severely impaired liver or kidney function, and patients in acute shock should not use this medication. It should not be administered to children under 2 years of age. Patients with impaired kidney function, diabetes, or liver dysfunction should be particularly cautious when using this medication and should administer it under strict medical supervision. During administration, regular checks of lipid levels, electrolyte concentrations, blood glucose, and liver enzyme levels in the blood should be conducted to ensure no abnormalities exist. Overdose may lead to hyperlipidemia, hyperglycemia, allergic reactions, etc., and the rate and dosage of administration must be strictly adjusted. Aseptic conditions must be maintained to prevent infections during administration and the injection site should be frequently monitored to avoid thrombosis or inflammation. Women who are pregnant or breastfeeding should only use this medication under medical judgment due to insufficient assurance of safety.

Serious side effects

Anaphylactic reactions (fever, chills, rash, difficulty breathing), hives, difficulty breathing, skin rash, hives, cyanosis, pallor, severe allergic reactions, high fever with severe rash, blisters, skin peeling, severe mucosal pain in mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, respiratory issues, yellowing of skin or eyes (jaundice), malaise

Mild side effects

• Loss of appetite
• nausea
• vomiting
• increased plasma liver enzyme levels
• thrombophlebitis
• hypotension
• hypertension
• mild increase in body temperature
• chills
• headache

This medication should be stored in a sealed container to prevent air exposure and kept in a cool place below 25 degrees Celsius. Take care not to freeze, as freezing may change the components of the medication.

Appearance

Consists of a colorless, transparent plastic inner bag divided into 3 compartments and an outer packaging, with an oxygen absorber in between. Each inner bag contains a colorless to pale yellow transparent amino acid solution.

Package unit

217 mL/bag (A solution: 68 mL, B solution: 118 mL, C solution: 31 mL), 241 mL/bag (A solution: 76 mL, B solution: 131 mL, C solution: 34 mL), 362 mL/bag (A solution: 114 mL, B solution: 197 mL, C solution: 51 mL), 500 mL/bag (A solution: 157.5 mL, B solution: 272 mL, C solution: 70.5 mL), 603 mL/bag (A solution: 190 mL, B solution: 328 mL, C solution: 85 mL), 1206 mL/bag